Schalop Lee Troy
SEC insider (Form 3/4/5 filer). CIK 0002072339. Director at Lantern Pharma Inc. (LTRN). 4 reported Form 4/5 transactions since Sep 2024; latest on May 12, 2026. Located in DALLAS, TX.
Companies Schalop Lee Troy has filed insider reports for
- Lantern Pharma Inc. (LTRN): Director
Schalop Lee Troy
CIK: 0002072339
Transaction Breakdown
Open Market Buys (P)1 (25.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)3 (75.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
LTRN
Lantern Pharma Inc.
Director
Discretionary Trading P&L
Holdings
Transaction History (4 total)
- May 12, 2026LTRN
Lantern Pharma Inc.
PurchaseDirect48.5K shares at avg. $2.06$100K - Jan 9, 2026LTRN
Lantern Pharma Inc.
AwardDirectStock Option (Right to Buy)
25K shares- - Jan 9, 2026LTRN
Lantern Pharma Inc.
AwardDirectStock Option (Right to Buy)
18.5K shares- - Aug 19, 2025LTRN
Lantern Pharma Inc.
AwardDirectStock Option (Right to Buy)
5K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| May 12, 2026 | LTRN Lantern Pharma Inc. | Purchase | 48,544 | $2.06 | $100,001 | Direct |
| Jan 9, 2026 | LTRN Lantern Pharma Inc. | Award Stock Option (Right to Buy) | 25,000 | - | - | Direct |
| Jan 9, 2026 | LTRN Lantern Pharma Inc. | Award Stock Option (Right to Buy) | 18,460 | - | - | Direct |
| Aug 19, 2025 | LTRN Lantern Pharma Inc. | Award Stock Option (Right to Buy) | 5,000 | - | - | Direct |
1-4 of 4 transactions